BIOHAVEN AND SK BIOPHARMACEUTICALS ENTER INTO STRATEGIC GLOBAL LICENSING AGREEMENT FOR NOVEL KV7 ION CHANNEL PLATFORM AND OPAKALIM, LEAD CANDIDATE FOR EPILEPSY

Reuters · 2d ago

Please log in to view news